The invention relates to antibodies directed to vascular endothelial growth factor ("VEGF") and uses of such antibodies, for example to treat diseases associated with the activity and/or overproduction of VEGF.
申请公布号
UA104626(C2)
申请公布日期
2014.02.25
申请号
UA20110014515
申请日期
2010.06.17
申请人
ABBVIE BIOTHERAPEUTICS INC.
发明人
HARDING, FIONA;AKAMATSU, YOSHIKO;DUBRIDGE, ROBERT, B.;POWERS, DAVID, B.
